3',5'-difluorobiphenyl-2-ylamine | 873056-60-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3',5'-difluorobiphenyl-2-ylamine
• 英文别名: 2-(3,5-Difluorophenyl)aniline
• CAS: 873056-60-1
• 化学式: C₁₂H₉F₂N
• 分子量: 205.207
• InChiKey: CYILCTRYEHZDGM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3',5'-difluorobiphenyl-2-ylamine 在 三乙胺 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 1.5h， 生成
  参考文献：
  名称：

  Transition-Metal-Free Synthesis of Phenanthridinones from Biaryl-2-oxamic Acid under Radical Conditions

  摘要：

  Na2S2O8-promoted decarboxylative cyclization of biaryl-2-oxamic acid for phenanthridinones has been developed. This work illustrates the first example of intramolecular decarboxylative amidation of unactivated arene under transition-metal-free conditions. Additionally, this approach provides an efficient and economical method to access biologically interesting phenanthridinones, an important structure motif in many natural products.

  DOI：

  10.1021/ol503459s
• 作为产物：
  描述：

  1-溴-3,5-二氟苯 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 tin(II) chloride dihdyrate 、 potassium carbonate 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 5.0h， 生成 3',5'-difluorobiphenyl-2-ylamine
  参考文献：
  名称：

  Transition-Metal-Free Synthesis of Phenanthridinones from Biaryl-2-oxamic Acid under Radical Conditions

  摘要：

  Na2S2O8-promoted decarboxylative cyclization of biaryl-2-oxamic acid for phenanthridinones has been developed. This work illustrates the first example of intramolecular decarboxylative amidation of unactivated arene under transition-metal-free conditions. Additionally, this approach provides an efficient and economical method to access biologically interesting phenanthridinones, an important structure motif in many natural products.

  DOI：

  10.1021/ol503459s

文献信息

• Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20150231142A1

  公开（公告）日：2015-08-20

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及含有上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
  申请人：Van Goor Fredrick F.

  公开号：US20110098311A1

  公开（公告）日：2011-04-28

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及包含上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
  申请人：Sheth Urvi

  公开号：US20120309758A1

  公开（公告）日：2012-12-06

  The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

  本发明涉及调节ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜传导调节蛋白，以及相关的组合物和方法。本发明还涉及使用这些调节剂治疗ABC转运蛋白介导的疾病的方法。
• Sequential C−H Borylation and N‐Demethylation of 1,1′‐Biphenylamines: Alternative Route to Polycyclic BN‐Heteroarenes
  作者：Jianbo Zhang、Hoimin Jung、Dongwook Kim、Sehoon Park、Sukbok Chang

  DOI：10.1002/anie.201902499

  日期：2019.5.27

  sequential borane‐mediated C(sp2)−H borylation and intramolecular N‐demethylation. The conveniently in situ generated Piers’ borane from a borinic acid reacts with a series of N,N‐dimethyl‐1,1′‐biphenyl‐2‐amines in the presence of PhSiH3 to afford six‐membered amine‐borane adducts bearing a C(sp2)−B bond at the C2′‐position. These species undergo an intramolecular N‐demethylation with a B(C6F5)3 catalyst to

  本文描述了通过连续的硼烷介导的C（sp 2）-H硼化和分子内N-去甲基化从1,1'-联苯胺获得BN-多芳族化合物的空前途径。在PhSiH 3存在下，由硼酸方便地就地生成的Piers'硼烷与一系列N，N-二甲基-1,1'-联苯-2-胺反应，得到六元胺-硼烷加合物在C2'位置的C（sp 2）-B键。这些物种通过B（C 6 F 5）3进行分子内N-去甲基化提供多芳族化合物的BN-等排体的催化剂。根据计算研究，提出了逐步的离子途径。所产生的BN-杂芳烃的光物理特征表明它们与全碳类似物具有显着差异。
• Method For Manufacturing Aryl Carboxamides
  申请人：Reichert Wolfgang

  公开号：US20110054183A1

  公开（公告）日：2011-03-03

  A process for preparing arylcarboxamides of the formula (I) where Ar =a mono- to trisubstituted phenyl, pyridyl or pyrazolyl ring, where the substituents are selected from halogen, C i -C 4 -alkyl and C 1 -C 4 -haloalkyl; M =thienyl or phenyl, which may bear a halogen substituent; Q =direct bond, cyclopropylene, fused bicycio[2.2.1]heptane or bicyclo[2.2.1]heptene ring; R 1 =hydrogen, halogen, C 1 -C 6 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, mono- to trisubstituted phenyl, where the substituents are selected from halogen and trifluoromethylthio, or cyclopropyl; by reacting an acid chloride of the formula (II) with an arylamine (III) in a suitable nonaqueous solvent, wherein, in the absence of an auxiliary base, a) the acid chloride (II) is initially charged, b) a pressure of from 0 to 700 mbar is established, c) the arylamine (III) is metered in in an approximately stoichiometric amount and d) the product of value is isolated.

  一种制备式(I)的芳基羧酰胺的方法，其中Ar = 单取代至三取代苯基、吡啶基或吡唑基环，取代基选自卤素、Ci-C4-烷基和C1-C4-卤代烷基；M = 噻吩基或苯基，可以带有卤素取代基；Q = 直链键、环丙烯基、融合的双环[2.2.1]庚烷或双环[2.2.1]庚烯环；R1 = 氢、卤素、C1-C6-烷基、C1-C4-烷氧基、C1-C4-卤代烷氧基、单取代至三取代苯基，其中取代基选自卤素和三氟甲硫基，或环丙基；通过在适当的非水溶剂中将式(II)的酸氯与芳香胺(III)反应，其中，在没有辅助碱的情况下，a) 首先加入酸氯(II)，b) 建立0至700毫巴的压力，c) 以近似化学计量的量滴定芳香胺(III)，d) 分离所得产物的价值。